Search Results - "Uvarova, E N"

Refine Results
  1. 1

    Pharmacokinetic (Bioavailability) Studies of Magnesium Preparations by Eremenko, N. N., Shikh, E. V., Uvarova, N. E.

    “…In order to obtain valid results when studying the bioavailability of medicinal products containing magnesium salts, it is necessary to take into account…”
    Get full text
    Journal Article
  2. 2

    Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza by Gubenko, A. I., Shukshina, G. V., Muravieva, A. I., Uvarova, N. E.

    “…Scientific relevance. The development of new medicinal products to treat influenza is motivated by the limitations of existing treatment options, the emergence…”
    Get full text
    Journal Article
  3. 3

    Planning and Evaluation of Bioequivalence Studies of Drugs with Nonlinear Pharmacokinetics by Uvarova, N. E., Eremenko, N. N., Ramenskaya, G. V., Goryachev, D. V.

    Published in Pharmaceutical chemistry journal (01-04-2021)
    “…A bioequivalence (BE) study is one of the key stages of investigations required for the registration of oral generic drugs. The planning of this type of study…”
    Get full text
    Journal Article
  4. 4

    Marketing Authorisation Based on Incomplete Clinical Data: International Experience and Prospects by Goryachev, D. V., Uvarova, N. E., Shukshina, G. V.

    “…No new drug can be used in clinical practice without marketing authorisation. Acquisition of the necessary amount of clinical data may take several years,…”
    Get full text
    Journal Article
  5. 5

    Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies by Goryachev, D. V., Uvarova, N. E.

    “…Generic drugs are widely discussed in the scientific literature. Their key advantage is high availability in the medical practice due to the possibility of a…”
    Get full text
    Journal Article
  6. 6

    Planning and Evaluation of Bioequivalence Studies of Lopinavir/Ritonavir Preparations by Uvarova, N. E., Eremenko, N. N., Ramenskaya, G. V., Goryachev, D. V.

    Published in Pharmaceutical chemistry journal (01-03-2020)
    “…Issues with planning bioequivalence studies of lopinavir/ritonavir (LPV/RTV) preparations are discussed. LPV is an antiviral (HIV) medicine and HIV protease…”
    Get full text
    Journal Article
  7. 7

    Assessment of the Feasibility of Therapeutic Equivalence Studies by Goryachev, D. V., Uvarova, N. E.

    “…The introduction of the «therapeutic equivalence» concept into the Russian legislation is critical for evaluation of medicines interchangeability and for…”
    Get full text
    Journal Article
  8. 8

    Comparison of FDA (2018) and EAEU Regulatory Requirements for Bioanalytical Method Validation by Uvarova, N. E., Eremenko, N. N., Ramenskaya, G. V., Goryachev, D. V., Smirnov, V. V.

    Published in Pharmaceutical chemistry journal (01-11-2019)
    “…US FDA requirements published in the new 2018 guidance for bioanalytical method validation and the necessity to confirm their reliability for determining…”
    Get full text
    Journal Article
  9. 9

    Planning and Assessment of Bioequivalence Studies of Darunavir Preparations by Uvarova, N. E., Eremenko, N. N., Ramenskaya, G. V., Goryachev, D. V.

    Published in Pharmaceutical chemistry journal (01-12-2018)
    “…Planning issues for darunavir (DRV) bioequivalence studies are considered. DRV is an antiviral (HIV) agent classified as an HIV protease inhibitor…”
    Get full text
    Journal Article
  10. 10

    NON-BIOLOGICAL COMPLEX DRUGS CONCEPT IN GENERIC DRUGS DEVELOPMENT by D. V. Goryachev, Yu. V. Chernova, N. E. Uvarova

    “…Expansion of the range of new medicines leads to a significant increase in healthcare spending and, consequently, to the appearance of more affordable generic…”
    Get full text
    Journal Article
  11. 11

    PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS by N. E. Uvarova, N. N. Eremenko, G. V. Ramenskaya, D. V. Goryachev

    “…The Government of the Russian Federation approved the State strategy of combating the spread of HIV aimed at prevention of HIV epidemic. One of the goals of…”
    Get full text
    Journal Article
  12. 12

    High-temperature resistant glass-ceramics based on Sr-anorthite and tialite phases by Orlova, L.A., Popovich, N.V., Uvarova, N.E., Paleari, A., Sarkisov, P.D.

    Published in Ceramics international (01-12-2012)
    “…We have identified a convenient strategy for the control of the thermal growth of monoclinic Sr-anorthite and tialite phases in Sr–Ti–Al–silicates. The…”
    Get full text
    Journal Article
  13. 13

    Clustering of discrete cell properties essential for tumorigenicity and metastasis. III. Dissociation of the properties in N-ras-transfected RSV-SR-transformed cells by Deichman, G I, Topol, L Z, Kluchareva, T E, Matveeva, V A, Zakamaldina, T A, Uvarova, E N, Tatosyan, A G

    Published in International journal of cancer (30-07-1992)
    “…We have previously shown that RSV-SR-transformed hamster cells acquire high resistance to H2O2, i.e. the cytotoxic product of activated macrophages (H2O2R) and…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Generic drugs of direct antiviral action for the treatment of hepatitis C: features of bioequivalence studies by Eremenko, N. N., Uvarova, N. E., Serebrova, S. Yu, Demchenkova, E. Yu, Shikh, E. V.

    Published in Medicinskij sovet (25-05-2023)
    “…Introduction . In the last decade, approaches to the treatment of chronic viral hepatitis C (HCV) have undergone significant changes. The new WHO strategy aims…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20